| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 4 securities · passive | ||||||
|
John Hancock Marathon Asset-Based Lending Fund
13G/A
478025109
|
0% |
7/14/2026
Event 7/8/2026
|
||||
|
Keenova Therapeutics plc
13G/A
MNKTQ · G5890A102
|
6.8% |
5/15/2026
Event 3/31/2026
|
||||
| Marathon Asset Management GP, L.L.C. | 6.8% | |||||
| Marathon Asset Management, L.P. | 6.8% | |||||
| Bruce Richards | 6.8% | |||||
| Louis Hanover | 6.8% | |||||
|
GrafTech International Ltd.
13G/A
EAF · 384313508
|
4.7% |
5/15/2026
Event 3/31/2026
|
||||
| Marathon Asset Management GP, L.L.C. | 4.7% | |||||
| Marathon Asset Management, L.P. | 4.7% | |||||
| MDCF II Investment Fund A SCSp | 3.5% | |||||
| Bruce Richards | 4.7% | |||||
| Louis Hanover | 4.7% | |||||
|
Endo, Inc.
13G/A
NDOI · 29290D117
|
8.0% |
5/15/2025
Event 3/31/2025
|
||||
| Marathon Asset Management GP, L.L.C. | 8.0% | |||||
| Marathon Asset Management LP | 8.0% | |||||
| Bruce Richards | 8.0% | |||||
| Louis Hanover | 8.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.